Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 1, 2022.
Article Versions
- Latest version (August 15, 2022 - 04:00).
- You are currently viewing a Latest version of this article (November 1, 2022 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Charis F. Meng,
- Diviya A. Rajesh,
- Deanna P. Jannat-Khah,
- Bridget Jivanelli and
- Vivian P. Bykerk
-
This research was supported by the Inflammatory Arthritis Center, Hospital for Special Surgery, New York, New York, USA.
C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery. D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College. B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA.
DPJK declares stock ownership in AstraZeneca, Cytodyn, and Walgreens. VPB declares institutional grants from BMS and Amgen; honoraria or consulting fees from Amgen, BMS, Genzyme, Gilead, Janssen, Pfizer, Sanofi-Aventis, and UCB; support by the National Institutes of Health (NIH; National Institute of Allergy and Infectious Diseases/National Institute of Arthritis and Musculoskeletal and Skin; grants 1UH2AR067691-01 and 11652401) and The Cedar Hill Foundation; and participation on the Data Safety Monitoring Board of NIH Cell Therapies. The remaining authors declare no conflicts of interest relevant to this article.
Address correspondence to Dr. C.F. Meng, Hospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. Email: mengc@hss.edu.
Accepted for publication July 27, 2022.